0002046762-25-000005.txt : 20251201 0002046762-25-000005.hdr.sgml : 20251201 20251201154524 ACCESSION NUMBER: 0002046762-25-000005 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251201 DATE AS OF CHANGE: 20251201 EFFECTIVENESS DATE: 20251201 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tasca Therapeutics Corp CENTRAL INDEX KEY: 0002046762 ORGANIZATION NAME: EIN: 872700874 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-530757 FILM NUMBER: 251539425 BUSINESS ADDRESS: STREET 1: 55 SPINELLI PLACE CITY: CAMBRIDGE STATE: MA ZIP: 02138 BUSINESS PHONE: 617-390-4306 MAIL ADDRESS: STREET 1: 55 SPINELLI PLACE CITY: CAMBRIDGE STATE: MA ZIP: 02138 D/A 1 primary_doc.xml X0708 D/A LIVE 0002046762 Tasca Therapeutics Corp 55 SPINELLI PLACE CAMBRIDGE MA MASSACHUSETTS 02138 617-390-4306 DELAWARE None None Corporation true 2021 Milenko Cicmil c/o Tasca Therapeutics Corporation 55 Spinelli Place Cambridge MA MASSACHUSETTS 02138 Executive Officer Director Drew King c/o Tasca Therapeutics Corporation 55 Spinelli Place Cambridge MA MASSACHUSETTS 02138 Executive Officer Xu Wu c/o Tasca Therapeutics Corporation 55 Spinelli Place Cambridge MA MASSACHUSETTS 02138 Director David Fallace c/o Tasca Therapeutics Corporation 55 Spinelli Place Cambridge MA MASSACHUSETTS 02138 Director Michael Aberman c/o Tasca Therapeutics Corporation 55 Spinelli Place Cambridge MA MASSACHUSETTS 02138 Director Praveen Tipirneni c/o Tasca Therapeutics Corporation 55 Spinelli Place Cambridge MA MASSACHUSETTS 02138 Director Seth Lieblich c/o Tasca Therapeutics Corporation 55 Spinelli Place Cambridge MA MASSACHUSETTS 02138 Director Biotechnology Decline to Disclose 06b true 0002046762-24-000001 2024-11-13 false true false 0 70199981 48099985 22099996 false 9 0 0 0 The proceeds are available to fund general working capital requirements; as of the date of this filing, no detailed operating budget has been adopted; and no proceeds have been or are proposed to be used for payments of finders fees or other compensation. false Tasca Therapeutics Corp /s/ Milenko Cicmil Milenko Cicmil President and CEO 2025-12-01